Kouichi Miura

11PUBLICATIONS
31CO-AUTHORS
Social program evaluationMetabolic medicinePredictive and prognostic markersNutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 01, 2026
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study.

Satoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka

|Feb 25, 2025
Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose.

Satoshi Shinozaki, Kouichi Miura, Toshiyuki Tahara

|Nov 27, 2024
Non-Targeted Metabolomics Reveal Apomorphine's Therapeutic Effects and Lysophospholipid Alterations in Steatohepatitis.

Hideo Ogiso, Kouichi Miura, Ryozo Nagai

|Jul 27, 2024
Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis.

Hiroshi Maeda, Kouichi Miura, Kenichi Aizawa

|Feb 21, 2024
Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence.

Xian-Yang Qin, Yohei Shirakami, Masao Honda

|Jun 28, 2023
Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study.

Satoshi Shinozaki, Toshiyuki Tahara, Kouichi Miura

Pageof 2

Frequent Collaborators

2 joint publications

Satoshi Shinozaki

2 joint publications

Hitoshi Osaka

1 joint publications

Hiroaki Okamoto

1 joint publications

Kazuhiko Kotani